Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Coherus Biosciences ( (CHRS) ) has shared an update.
Kimberly J. Tzoumakas has announced her resignation from the Board of Directors of Coherus BioSciences, Inc., effective December 31, 2024. Her departure is amicable, with no disagreements over company operations or policies, reflecting a positive relationship and her valued contributions during her time with the board.
See more data about CHRS stock on TipRanks’ Stock Analysis page.